Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $5.23 million. The enterprise value is $13.05 million.
| Market Cap | 5.23M |
| Enterprise Value | 13.05M |
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IBO has 12.09 million shares outstanding. The number of shares has decreased by -75.02% in one year.
| Current Share Class | 12.09M |
| Shares Outstanding | 12.09M |
| Shares Change (YoY) | -75.02% |
| Shares Change (QoQ) | +4.81% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 3.19% |
| Float | 11.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 1.34.
| Current Ratio | 0.22 |
| Quick Ratio | 0.13 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.29 |
Financial Efficiency
Return on equity (ROE) is -147.03% and return on invested capital (ROIC) is -8.12%.
| Return on Equity (ROE) | -147.03% |
| Return on Assets (ROA) | -7.06% |
| Return on Invested Capital (ROIC) | -8.12% |
| Return on Capital Employed (ROCE) | -36.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$12.51M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IBO has paid $33,000 in taxes.
| Income Tax | 33,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.43 |
| Average Volume (20 Days) | 314,064 |
Short Selling Information
The latest short interest is 346,705, so 2.87% of the outstanding shares have been sold short.
| Short Interest | 346,705 |
| Short Previous Month | 282,967 |
| Short % of Shares Out | 2.87% |
| Short % of Float | 2.98% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.64M |
| Pretax Income | -8.34M |
| Net Income | -25.01M |
| EBITDA | -3.63M |
| EBIT | -3.64M |
| Earnings Per Share (EPS) | -$2.22 |
Balance Sheet
The company has $1.32 million in cash and $9.14 million in debt, giving a net cash position of -$7.82 million or -$0.65 per share.
| Cash & Cash Equivalents | 1.32M |
| Total Debt | 9.14M |
| Net Cash | -7.82M |
| Net Cash Per Share | -$0.65 |
| Equity (Book Value) | 6.81M |
| Book Value Per Share | 0.31 |
| Working Capital | -7.79M |
Cash Flow
| Operating Cash Flow | -4.12M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.12M |
| FCF Per Share | -$0.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 75.02% |
| Shareholder Yield | 75.02% |
| Earnings Yield | -478.65% |
| FCF Yield | -78.82% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |